Menu
Back to Journals
Clinical Pharmacology: Advances and Applications
ISSN: 1179-1438
Professor Arthur E. Frankel
Professor Frankel
Chief of Hematology & Oncology, Department of Medicine, West Palm Beach VA Medical Center, West Palm Beach, FL, USA
Arthur E. Frankel, MD was born in Austin, Texas, attended Harvard College and Harvard Medical School and completed medical training at Yale University, the National Institutes of Health and Stanford University. He practiced and taught at Duke University, the Medical University of South Carolina, Wake Forest University, Texas A&M, the University of Texas Southwestern, and the University of South Alabama. He is now Chief Hematology and Oncology at the West Palm Beach VA Medical Center.
His clinical focus is malignant hematology, cutaneous malignancies and GU cancers. He has done research including the discovery of the first mammalian oncogenes, the generation of the first Her2 and PSA monoclonal antibodies, the finding of one of the first second site revertant enzyme mutations, discovery of a third lectin binding site on the plant toxin ricin, production of anti-leukemia fusion proteins, and reporting the first gut microbes critical for melanoma immunotherapy response. His interleukin 3-directed fusion protein was approved by the FDA in 2018 for a rare type of leukemia. His current goal is to provide outstanding and cutting edge clinical care to veterans.
Dr Khaled Deeb
Dr Deeb
Associate Professor in Information Technology, West Palm Beach VA Medical Center, West Palm Beach, FL, USA
Dr. Khaled Deeb is an Associate Professor and global expert in computer science, medical informatics, and internal medicine holding two doctoral degrees. He has served as the program director and designed undergraduate and graduate programs in the research areas of business management, data mining, software engineering, and artificial intelligence.
He has published many articles in leading publications and chaired several conferences and workshops. He has also collaborated on interdisciplinary research projects and grants with various universities and government entities (e.g., CDC). He is a global expert consultant at both the private and public sectors in the fields of health services, business management, software, and technologies. He has earned several awards for scholarship, community service, professional service, and teaching excellence.
Dr. Deeb bridges traditional and contemporary medicine to develop highly unconventional approaches that revolutionize medical practice to help redefine the future of medicine and patient care through personalized medicine and intelligent healthcare informatics. His research goals are to improve well-being and aging by bringing together the science of medicine and bioinformatics.
Editorial Board
Dr Aboukaoud
Dr. Mohammed Aboukaoud, PharmD, MD, Department of Biochemistry and Clinical Pharmacology, Ben Gurion University, Israel
Dr Cho
Dr Cho, Ph.D., Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, People's Republic of China.
Professor Cook
James M. Cook, University Distinguished Professor, Organic Chemistry, Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI, USA
Professor Dajani
Esam Z. Dajani, President, IDDC Corporation; Adjunct Professor of Medicine, Loyola University-Chicago, Chicago, Illinois, USA
Prof. Dr. Foldvari
Marianna Foldvari, Professor of Pharmaceutical Sciences, School of Pharmacy, University of Waterloo, ON, Canada
Prof. Dr. Fuchs
Hendrik Fuchs, Professor for Target Cell Directed Tumor Therapy, Head of the Laboratory of Molecular Tumor Therapy and Deputy Director of the Department of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité - Universitätsmedizin Berlin, Germany.
Professor Ganju
Ramesh Ganju, Scott Endowed Professor of Pathology, Vice-Chair Experimental Pathology, Ohio State University, Columbus, OH, USA
Professor Kaufman
Paul L Kaufman, Ernst H. Bárány Professor of Ocular Pharmacology Emeritus, Department Chair Emeritus, Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Dr Khushman
Moh’d Khushman, M.D, Associate Professor of Medicine, GI Medical Oncologist Division of Medical Oncology, Department of Medicine, Washington University in St. Louis, USA
Dr Kreitman
Robert J. Kreitman, Chief, Clinical Immunotherapy Section, Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Professor London
Edythe London, Professor In-Residence, Psychiatry and Biobehavioral Sciences Molecular & Medical Pharmacology Member, Brain Research Institute, CTSI Molecular Pharmacology, UCLA, Los Angeles, CA, USA
Professor Naik
Eknath Naik, MD, PhD, MSPH, FACP, FACHE, Professor of Public Heath and Medicine, Deputy Chief of Staff for Clinical and Quality Outcomes, University of South Florida, USA
Dr North
William G. North, Professor of Physiology, Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth College, Hanover NH USA
Professor Pan
Hui-Lin Pan, Helen T. Hawkins Distinguished Professor and Deputy Division Head for Research, Department of Anesthesiology and Perioperative Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Dr Patel
Associate Professor of Anesthesiology, Gaurav P. Patel, MD, FASA, Department of Anesthesiology, Emory University School of Medicine, USA
Professor Redei
Eva E. Redei, Ph.D.David Lawrence Stein Professor of Psychiatry, Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University
Professor Remick
Scot C. Remick, MD, Chief, MaineHealth Cancer Care Network, Maine Medical Center Cancer Institute, Portland, ME; Professor Tufts University School of Medicine, Boston MA, USA
Professor Sachdeva
Mandip Singh Sachdeva, Professor, Pharmaceutics, College of Pharmacy, Florida A&M University, FL, USA
Prof. Dr. Safe
Stephen H. Safe, Distinguished Professor, Department of Veterinary Physiology and Pharmacology, Texas A&M University and Health Science Center, College Station, TX, USA
Professor Vallera
Daniel A. Vallera, Professor of Therapeutic Radiology - Radiation Oncology, Lion Scholar and Director, Section on Molecular Cancer Therapeutics, University of Minnesota Cancer Center, Minnesota, USA
Professor Wang
Donna Wang, Distinguished Professor, Chief, Division of Nanomedicine and Molecular Intervention, Michigan State University, East Lansing, Michigan, USA